Adenocarcinoma Of Esophagus Terminated Phase 2 Trials for Fluorouracil (DB00544)

Also known as: Adenocarcinoma of Oesophagus / Oesophageal Adenocarcinoma / Adenocarcinoma, Esophageal / Esophageal Adenocarcinomas / Esophageal Adenocarcinoma / Oesophageal adenocarcinoma NOS

IndicationStatusPhase
DBCOND0067383 (Adenocarcinoma Of Esophagus)Terminated2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT01307956Panitumumab, Combination Chemotherapy, and Radiation Therapy Before Surgery in Treating Patients With Advanced Esophageal or Gastroesophageal Junction CancerTreatment